Stifel Nicolaus's Rick Wise upgraded their rating on Lemaitre Vascular (NASDAQ: LMAT) from Hold to Strong Buy on 2024/04/26. The analyst also raised their price target by 27.1% from $59 to $75. Wise's...
Source LinkStifel Nicolaus's Rick Wise upgraded their rating on Lemaitre Vascular (NASDAQ: LMAT) from Hold to Strong Buy on 2024/04/26. The analyst also raised their price target by 27.1% from $59 to $75. Wise's...
Source Link
Comments